Hysterectomy, endometrial ablation and Mirena® for heavy menstrual bleeding: a systematic review of clinical effectiveness and cost-effectiveness analysis

Hysterectomy, endometrial ablation and Mirena® for heavy menstrual bleeding: a systematic review of clinical effectiveness and cost-effectiveness analysis

Objective: The aim of this project was to determine the clinical effectiveness and cost-effectiveness of hysterectomy, first- and second-generation endometrial ablation (EA), and Mirena® (Bayer Healthcare Pharmaceuticals, Pittsburgh, PA, USA) for the treatment of heavy menstrual bleeding. Design: In...

Full description

Bibliographic Details
Main Authors: S Bhattacharya, LJ Middleton, A Tsourapas, AJ Lee, R Champaneria, JP Daniels, T Roberts, NH Hilken, P Barton, R Gray, KS Khan, P Chien, P O’Donovan, KG Cooper, International Heavy Menstrual Bleeding Individual Patient Data Meta-analysis Collaborative Group
Format: Article
Language:English
Published: NIHR Journals Library 2011-04-01
Series:Health Technology Assessment
Subjects:
hysterectomy
endometrial ablation
mirena
menstrual bleeding
systematic review
Online Access:https://doi.org/10.3310/hta15190

Internet

https://doi.org/10.3310/hta15190

Similar Items